72.94MGBP
-0.53
Type
Common Stock
Exchange
LSE
Currency Code
GBX
Currency Name
Pence sterling
Country Name
UK
Country ISO
GB
ISIN
GB00BSNB6S51
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.1
Wall Street Target Price
130.00
EPS Estimate Current Year
-6.21
EPS Estimate Next Year
-10.13
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
4,202,000
Gross Profit TTM
18,690,000
EBITDA
-30,555,000
Profit Margin
0.00%
Return On Assets TTM
-43.95%
Return On Equity TTM
-180.80%
Revenue Per Share TTM
0.013
Qtly Revenue Growth YOY
-81.70%
Diluted Eps TTM
-0.1
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.6372
Price Book MRQ
9.5652
Enterprise Value Revenue
7
Enterprise Value EBITDA
-1
32.50
6.56%321.00
2.39%129.20
1.57%119.80
1.10%1960.00
1.03%105.50
0.96%142.00
0.00%2600.00
0.00%1346.00
0.00%1378.00
-1.77%